在中国优化宫癌预防战略:综合建模分析
Dachuang Zhou1,2, Di Zhang1,2, Yi Wang1,2
1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
Cost effectiveness and resource allocation : C/E
|May 14, 2025
概括
对于中国来说,最适合的宫癌预防策略包括对35-64岁的妇女进行查,用酸视觉检查 (VIA),并用双价人乳头瘤病毒 (HPV) 疫苗接种9-14岁的女孩. 这种方法是有效的,具有成本效益和负担得起的,与消除目标保持一致.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 卫生经济学 卫生经济学
背景情况:
- 中国正准备推出其首个国内的9价值人类乳头瘤病毒 (HPV) 疫苗.
- 宫癌查技术的进步也在出现.
- 需要为中国确定最佳的宫癌预防策略.
研究的目的:
- 为中国评估和确定有效,具有成本效益和负担得起的宫癌预防策略.
- 评估与世界卫生组织 (WHO) 的宫癌消除目标相对应的战略.
- 考虑目前的预算和对干预措施的潜在降价.
主要方法:
- 从医疗保健系统的角度开发了一个马尔科夫模型.
- 该模型包括18个年龄层和9个健康状况,模拟了30年来38个预防策略.
- 模型参数是使用现实数据进行校准的;战略是根据世卫组织的目标,成本效益门和预算限制来评估的.
主要成果:
- 16个策略可以在2050年前实现宫癌消除;29个是高成本效益的;11个是负担得起的.
- 对35-64岁的女性进行查,用乙酸视觉检查 (VIA) 与9-14岁女孩的双价HPV疫苗接种相结合,符合所有标准.
- 这种最佳策略可以在2041年以2543.91美元/QALY的ICER实现淘汰,并被认为是负担得起的. 敏感性分析证实了强度.
结论:
- 对35-64岁的女性进行VIA查,并用双价HPV疫苗接种9-14岁女孩的疫苗是中国最适合的宫癌预防策略.
- 更先进的查方法和9价值HPV疫苗在增加预算的情况下可能是可行的.
- 这项研究为中国的宫癌预防和控制政策提供了关键证据.
相关概念视频
Cancer Survival Analysis
311
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
311
Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


